Literature DB >> 32192566

Zinc and Probiotic Therapy for Management of Hepatic Encephalopathy.

Alessa D Gonzales, Justin P Reinert.   

Abstract

Hepatic encephalopathy is a complication of decompensated liver disease that consumes considerable health care resources and has a negative impact on quality of life. For several decades, maintenance therapy with lactulose has been considered the standard of care, but emerging data from clinical trials demonstrate that other therapeutic options may be available and could have a better tolerability profile than lactulose. This brief review will discuss the pathophysiology of hepatic encephalopathy and proposed mechanisms of action of zinc and probiotics in this context, discussing the findings of key trials.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32192566     DOI: 10.4140/TCP.n.2020.171.

Source DB:  PubMed          Journal:  Sr Care Pharm        ISSN: 2639-9636


  2 in total

Review 1.  Gut Microbiota as a Mediator of Essential and Toxic Effects of Zinc in the Intestines and Other Tissues.

Authors:  Anatoly V Skalny; Michael Aschner; Xin Gen Lei; Viktor A Gritsenko; Abel Santamaria; Svetlana I Alekseenko; Nagaraja Tejo Prakash; Jung-Su Chang; Elena A Sizova; Jane C J Chao; Jan Aaseth; Alexey A Tinkov
Journal:  Int J Mol Sci       Date:  2021-12-03       Impact factor: 5.923

2.  [Betelnut polyphenols provide protection against high-altitude hypoxia in rats].

Authors:  Y Huo; A Zhao; J Song; J Li; R Wang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-05-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.